脆弱人群疫苗安全性与有效性生物标志物:第四届国际精准疫苗会议的经验
第四届国际精准疫苗会议在罗马召开,由波士顿儿童医院精准疫苗项目与耶稣圣婴儿童医院共同主办,聚焦脆弱人群疫苗安全性与有效性生物标志物。会议讨论了评估疫苗安全性、定义免疫原性生物标志物、开发人体体外检测模型及加速筛选适配脆弱人群的新疫苗配方与佐剂,强调多学科策略与国际合作。
要点
- 脆弱人群包括极端年龄组及有基础健康状况者,其疫苗应答不佳且接种不足。
- 会议聚焦疫苗安全性评估、免疫原性生物标志物及人体体外检测模型。
- 需多学科策略与国际合作以优化脆弱人群精准疫苗开发。
核心结论
- 会议强调精准疫苗对满足脆弱人群独特需求的重要性,并指出需多学科策略与国际合作来优化疫苗开发。
研究设计与样本
- 第四届国际精准疫苗会议于罗马召开,由波士顿儿童医院精准疫苗项目与耶稣圣婴儿童医院共同主办,专家来自免疫学、儿科学和疫苗学等领域。
主要发现
- 脆弱人群承受不成比例的传染病发病与死亡负担,且存在接种不足、疫苗应答欠佳及疫苗诱导保护机制不同等挑战。
- 会议重点讨论了评估疫苗安全性、定义疫苗免疫原性生物标志物、开发人体体外检测模型以及加速筛选适配脆弱人群的新疫苗配方与佐剂。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Vaccination has been a cornerstone of public health, substantially reducing the global burden of infectious diseases, notably evident during the COVID-19 pandemic caused by SARS-CoV-2. However, vulnerable populations (VPs), including those in extreme age groups and those with underlying health conditions, have borne a disproportionate burden of morbidity and mortality from infectious diseases. Understanding vaccine immunogenicity in these populations is crucial for developing effective vaccines. Characterizing vaccine responses in VPs presents unique challenges due to under-vaccination, sub-optimal vaccine responses, and distinct mechanisms of vaccine-induced protection. To address these challenges, experts convened at the 4th International Precision Vaccines Conference in Rome. Co-hosted by the Precision Vaccines Program of Boston Children's Hospital and Ospedale Pediatrico Bambino Gesù, the conference focused on biomarkers of vaccine safety and efficacy in vulnerable populations. Discussions at the conference emphasized the need for multidisciplinary strategies and international collaborations to optimize vaccine development. Key areas of focus included assessing vaccine safety, defining biomarkers for vaccine immunogenicity, developing human in vitro assay models, and accelerating the selection of novel vaccine formulations and adjuvants tailored for vulnerable populations. The conference provided a platform for experts from diverse fields, including immunology, paediatrics, and vaccinology, to exchange ideas and advance research in precision vaccines. This manuscript highlights key concepts discussed at the conference and underscores the importance of precision vaccines in addressing the unique needs of vulnerable populations.
引用
- Amodio D, Angelidou A, Cotugno N, et al. Biomarkers of vaccine safety and efficacy in vulnerable populations: Lessons from the fourth international precision vaccines conference. Vaccine. 2024. PMID: 39608233. doi:10.1016/j.vaccine.2024.126477
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。